BAYER AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
US Ovulation Inhibition Study in Obese Women
Phase 2
Completed
- Conditions
- Contraception
- Interventions
- Drug: Ethinylestradiol/Gestodene (BAY86-5016)
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 173
- Registration Number
- NCT00873483
Physical Disability in Patients Treated With Betaferon
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Interferon-1beta (Betaseron, BAY86-5046)
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 83
- Registration Number
- NCT00873340
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Phase 4
Terminated
- Conditions
- Anterior Ischemic Optic Neuropathy
- Interventions
- Drug: Diagnostic procedures
- First Posted Date
- 2009-03-24
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 10
- Registration Number
- NCT00867815
- Locations
- πΊπΈ
Retinal and Ophthalmic Consultants, Houston, Texas, United States
πΊπΈPalm Beach Eye Center, Atlantis, Florida, United States
πΊπΈNational Ophthalmic Research Institute, Fort Myers, Florida, United States
Mirena in Idiopathic Menorrhagia
Completed
- Conditions
- Idiopathic Menorrhagia
- Interventions
- First Posted Date
- 2009-03-24
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1125
- Registration Number
- NCT00868153
Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
Phase 2
Completed
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Drug: Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)Drug: Matching placebo + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 198
- Registration Number
- NCT00865709
Mirena or Conventional Medical Treatment for Menorrhagia
Completed
- Conditions
- Menorrhagia
- Interventions
- Drug: Conventional medical treatmentDrug: Levonorgestrel (Mirena, BAY86-5028)
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 647
- Registration Number
- NCT00864136
International PMS Study - KOGENATE Bayer
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 200
- Registration Number
- NCT00864552
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Bayer
- Target Recruit Count
- 396
- Registration Number
- NCT00863681
- Locations
- π΅πΉ
Centro Hospitalar de Lisboa Norte - Hospital Santa Maria, Lisboa, Portugal
π²π½Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico
π²π½Pulmocritic, Guadalajara, Jalisco, Mexico
A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).
Phase 3
Completed
- Conditions
- Non-Small-Cell LungCarcinoma
- Interventions
- Drug: Sorafenib (Nexavar, BAY43-9006)Drug: Placebo
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 703
- Registration Number
- NCT00863746
Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Phase 2
Completed
- Conditions
- Brain DiseasesSpinal Cord Diseases
- Interventions
- Drug: Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)Drug: Gadobutrol~0.1 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)Drug: Gadobutrol~0.3 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)Drug: OptiMARK~0.1 mmol/kg BW
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2014-01-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 237
- Registration Number
- NCT00862459
- Locations
- πΊπΈ
Boston Medical Center, Boston, Massachusetts, United States
πΊπΈUniversity of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, United States
πΊπΈJohns Hopkins University School of Medicine, Baltimore, Maryland, United States
Β© Copyright 2025. All Rights Reserved by MedPath